Time Source Company Announcement
22 Mar 2023 07:00 AM Rule 2.9 Announcement
22 Mar 2023 07:00 AM Director/PDMR Shareholding
22 Mar 2023 07:00 AM Grant of Options and PDMR Dealing
22 Mar 2023 07:00 AM Directorate Change
22 Mar 2023 07:00 AM Director/PDMR Shareholding
22 Mar 2023 07:00 AM 2022 Annual Results
22 Mar 2023 07:00 AM Final Results
22 Mar 2023 07:00 AM SPA Signed for Sale of IM Minerals
22 Mar 2023 07:00 AM Result of Tender Offer
22 Mar 2023 07:00 AM RCE-4 Results and Operations Update
22 Mar 2023 07:00 AM Preliminary results from Phase 1b study
22 Mar 2023 07:00 AM Final Results
22 Mar 2023 07:00 AM Full Year Results
22 Mar 2023 07:00 AM Interim Report
22 Mar 2023 07:00 AM Acquisition
22 Mar 2023 07:00 AM Preliminary results for the year ended 31 Dec 2022
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Operational Update
22 Mar 2023 07:00 AM Dividend Dates
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Half-Year Report
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Full-Year Results
22 Mar 2023 07:00 AM Trading update - a record year for Braemar
22 Mar 2023 07:00 AM Memorandum of Understanding with ELGO-DIMITRA
22 Mar 2023 07:00 AM Results for the year ended 31 December 2022
22 Mar 2023 07:00 AM Baillie Gifford Shin Nippon PLC Final Results
22 Mar 2023 07:00 AM Full Year Results
22 Mar 2023 07:00 AM Result of AGM
22 Mar 2023 07:00 AM Full Year Trading Update
22 Mar 2023 07:00 AM Trading Update
22 Mar 2023 07:00 AM Annual Financial Report
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
22 Mar 2023 07:00 AM Deferred Consideration & Total Voting Rights
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Pre-close trading update
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Final results for the 9 months to 31 December 2022
22 Mar 2023 07:00 AM Positive FDA Feedback to Progress Bexmarilimab
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Transaction in Own Shares
22 Mar 2023 07:00 AM Notice of Investor Meet Company Presentation
UK 100

Latest directors dealings